-
EP4045018
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4045018
| EP4045018 - METHODS AND COMPOSITIONS FOR CANCER TREATMENT USING NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON NK CELLS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 06.09.2024 Database last updated on 30.10.2024 | |
| Former | Request for examination was made Status updated on 22.07.2022 | ||
| Former | The international publication has been made Status updated on 24.04.2021 | Most recent event Tooltip | 06.09.2024 | Withdrawal of application | published on 09.10.2024 [2024/41] | Applicant(s) | For all designated states The University of North Carolina at Chapel Hill 109 Church Street Chapel Hill, North Carolina 27516 / US | [2022/34] | Inventor(s) | 01 /
WANG, Andrew 136 Turner Ridge Circle Durham, North Carolina 27713 / US | 02 /
AU, Kin Man 404 Jones Ferry Road Carrboro, North Carolina 27510 / US | [2022/34] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
| Former [2022/34] | FRKelly 27 Clyde Road Dublin D04 F838 / IE | Application number, filing date | 20876990.1 | 15.10.2020 | [2022/34] | WO2020US55818 | Priority number, date | US201962923060P | 18.10.2019 Original published format: US 201962923060 P | [2022/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021076780 | Date: | 22.04.2021 | Language: | EN | [2021/16] | Type: | A1 Application with search report | No.: | EP4045018 | Date: | 24.08.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.04.2021 takes the place of the publication of the European patent application. | [2022/34] | Search report(s) | International search report - published on: | KR | 22.04.2021 | (Supplementary) European search report - dispatched on: | EP | 13.12.2023 | Classification | IPC: | A61K47/69, A61K47/68, A61K31/704, A61P35/00, A61K9/51, C07K16/28, A61K39/00 | [2024/02] | CPC: |
A61K47/6937 (EP,IL,KR);
A61K9/5169 (KR);
A61K9/51 (US);
A61K31/704 (EP,IL,KR,US);
A61K39/395 (EP,IL);
A61K39/4613 (EP,IL,KR,US);
A61K39/464404 (EP,IL,KR,US);
A61K47/6849 (EP,IL);
A61K47/6851 (EP,IL);
A61K47/6935 (EP,IL,KR);
A61K9/5153 (KR);
A61P35/00 (EP,IL,KR,US);
C07K16/28 (EP,IL,KR);
C07K16/283 (EP,IL,KR);
C07K16/2863 (EP,IL,KR);
C07K16/2878 (EP,IL,KR);
A61K2300/00 (IL,KR);
C07K2317/73 (EP,IL,KR);
C07K2317/90 (EP,IL,KR)
(-)
| C-Set: |
A61K39/395, A61K2300/00 (EP)
|
| Former IPC [2022/34] | A61K9/51, A61K31/704, A61P35/00, C07K16/28, A61K39/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/34] | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR KREBSBEHANDLUNG UNTER VERWENDUNG VON MIT MEHREREN LIGANDEN ZUR BINDUNG VON REZEPTOREN AN NK-ZELLEN KONJUGIERTEN NANOPARTIKELN | [2022/34] | English: | METHODS AND COMPOSITIONS FOR CANCER TREATMENT USING NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON NK CELLS | [2022/34] | French: | PROCÉDÉS ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER UTILISANT DES NANOPARTICULES CONJUGUÉES À DE MULTIPLES LIGANDS POUR SE LIER À DES RÉCEPTEURS SUR DES CELLULES TUEUSES NATURELLES | [2022/34] | Entry into regional phase | 27.04.2022 | National basic fee paid | 27.04.2022 | Search fee paid | 27.04.2022 | Designation fee(s) paid | 27.04.2022 | Examination fee paid | Examination procedure | 27.04.2022 | Examination requested [2022/34] | 08.07.2024 | Amendment by applicant (claims and/or description) | 08.07.2024 | Date on which the examining division has become responsible | 02.09.2024 | Application withdrawn by applicant [2024/41] | Fees paid | Renewal fee | 15.09.2022 | Renewal fee patent year 03 | 14.09.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO2011071871 (UNIV LELAND STANFORD JUNIOR [US], et al); | [Y]US2017128585 (MARKOVIC SVETOMIR N [US], et al); | [XY]WO2017123627 (STC BIOLOGICS INC [US]); | [I]US2018208657 (JUNG GUNDRAM [DE], et al); | [XY]US2018369411 (YU HAOYANG [CN], et al); | International search | [A]US2016237137 (WEBB TONYA [US], et al); | [A]WO2018175473 (UNIV SOUTHERN CALIFORNIA [US]); | [A]US2019175755 (KOSMIDES ALYSSA K [US], et al); |